Literature DB >> 4035306

Negative symptoms in schizophrenia: their longitudinal course and prognostic importance.

M F Pogue-Geile, M Harrow.   

Abstract

Negative and positive symptoms were investigated longitudinally in 39 young schizophrenic patients at two followup assessments approximately 2.5 and 5 years after hospital discharge. Negative symptoms, such as flat affect and poverty of speech, which were assessed at the first followup, were found to be effective prognostic signs in schizophrenic patients for predicting later poor role functioning at the second followup. The prognostic importance of negative symptoms was predominantly due to their tendency to occur in patients who were already functioning poorly in social and instrumental areas at the first followup, and who tended to continue doing poorly at the second followup. Contrary to some current hypotheses, positive symptoms, such as delusions and hallucinations, were also found to be prognostic of later deficits in role functioning at the second followup. Negative symptoms appeared to be generally persistent over time, although there was some tendency toward remission. Potential models of the etiology of negative symptoms and their role in schizophrenia are proposed.

Entities:  

Mesh:

Year:  1985        PMID: 4035306     DOI: 10.1093/schbul/11.3.427

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  28 in total

Review 1.  Neuropsychiatric rehabilitation for persistent mental illness.

Authors:  J Jaeger; E Douglas
Journal:  Psychiatr Q       Date:  1992

Review 2.  Psychomotor slowing in schizophrenia.

Authors:  Manuel Morrens; Wouter Hulstijn; Bernard Sabbe
Journal:  Schizophr Bull       Date:  2006-11-08       Impact factor: 9.306

3.  Is disorganization a feature of schizophrenia or a modifying influence: evidence of covariation of perceptual and cognitive organization in a non-patient sample.

Authors:  Keith A Feigenson; Michael A Gara; Matthew W Roché; Steven M Silverstein
Journal:  Psychiatry Res       Date:  2014-03-12       Impact factor: 3.222

4.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

5.  Reliability and validity of the life functioning assessment inventory (L-FAI) for patients with psychosis.

Authors:  Christy Lai-Ming Hui; Yuet-Keung Li; Kwok-Fai Leung; Jennifer Yee-Man Tang; Gloria Hoi-Yan Wong; Wing-Chung Chang; Sherry Kit-Wa Chan; Edwin Ho-Ming Lee; Eric Yu-Hai Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-03-26       Impact factor: 4.328

6.  A Longitudinal Examination of the Moderating Effects of Symptoms on the Relationship between Functional Competence and Real World Functional Performance in Schizophrenia.

Authors:  Michael W Best; Maya Gupta; Christopher R Bowie; Philip D Harvey
Journal:  Schizophr Res Cogn       Date:  2014-06-01

7.  Effectiveness of Community Treatment Order in Patients with a First Episode of Psychosis: A Mirror-Image Study.

Authors:  Emmanuelle Levy; Sally Mustafa; Kanza Naveed; Ridha Joober
Journal:  Can J Psychiatry       Date:  2018-08-05       Impact factor: 4.356

8.  A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness.

Authors:  Aricca D Van Citters; Sarah I Pratt; Kenneth Jue; Gail Williams; Patricia T Miller; Haiyi Xie; Stephen J Bartels
Journal:  Community Ment Health J       Date:  2009-12-10

9.  Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.

Authors:  Tina Gupta; Henry R Cowan; Gregory P Strauss; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

10.  Apathy, poor verbal memory and male gender predict lower psychosocial functioning one year after the first treatment of psychosis.

Authors:  Ann Faerden; Elizabeth Ann Barrett; Ragnar Nesvåg; Svein Friis; Arnstein Finset; Stephen R Marder; Joseph Ventura; Ole A Andreassen; Ingrid Agartz; Ingrid Melle
Journal:  Psychiatry Res       Date:  2013-03-13       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.